| Model Number |
ETE |
| Medical Device Problem Code |
Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Hypopyon (1913); Visual Impairment (2138); Toxic Anterior Segment Syndrome (TASS) (4469)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that approximately five weeks after implantation of an intraocular lens (iol), the patient presented with fibrin and hypopyon in the anterior chamber.Visual acuity decreased to count fingers at 20 feet.Based on the clinical findings the surgeon concluded the cause as toxic anterior segment syndrome (tass).A tap procedure was performed, and a corticosteroid injection was administered.Due to the severity of the inflammation, oral corticosteroid therapy was initiated.The patient's condition subsequently improved; however, vision remains significantly reduced.Additional information was requested but was not received.
|
| |
|
Additional Manufacturer Narrative
|
|
The device remains implanted.A review of the device history record (dhr) did not identify any anomalies or nonconformities that could be related to this event.The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.Based on the available information, the root cause could not be conclusively determined.
|
| |
|
Search Alerts/Recalls
|